Clinical Trials Browser

Phase 2 × INDUSTRY × Breast Neoplasms, Male × Clear all

NCT00006370 2013-05-01

Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Lung Neoplasms, Breast Neoplasms, Male, Small Cell Lung Carcinoma

NCT00106002 2009-06-01

Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer

Phase 2 Completed

37 enrolled 9 charts

Breast Neoplasms, Breast Neoplasms, Male, Carcinoma, Ductal